24小时热门版块排行榜    

查看: 400  |  回复: 0

ienjoysun

银虫 (著名写手)

[交流] Horizon Pharma to acquire Vidara Therapeutics for around $660 million

Horizon Pharma to acquire Vidara Therapeutics for around $660 million
(Ref: The Wall Street Journal, NASDAQ, Marketwired, Yahoo!Finance, StreetInsider, The Irish Times)
March 19th, 2014
By: Joe Barber
Tags: Top Story Actimmune Duexis Lodotra Rayos Vimovo Horizon Pharma Vidara Corporate Affairs Mergers & Acquisitions



Horizon Pharma entered a definitive agreement to buy Vidara Therapeutics through a reverse stock-and-cash merger valued at approximately $660 million, the companies announced Wednesday. The transaction is aimed at helping Horizon transform to a profitable specialty pharmaceutical company, with CEO Timothy Walbert noting the merger gives it "a portfolio of four proprietary products and an international platform that builds on our strategy of organic growth and acquisitions."

Under the terms of the agreement, the combined drugmaker will operate under the Horizon Pharma name and be organised under Irish laws. Current stockholders of Horizon would own approximately 74 percent of the merged entity, while Vidara shareholders would hold about 26 percent and receive $200 million in cash. Further, Horizon's current officers will become officers of the combined company, including Walbert as president and CEO, with Vidara executives given "important leadership and management roles."

The deal will give Horizon rights to Vidara's biologic response modifier Actimmune (interferon gamma-1b). The therapy, which recorded sales of $58.9 million in 2013, is cleared in the US to treat chronic granulomatous disease and severe malignant osteopetrosis in children and adults. "The addition of Actimmune complements our commercial business model focused on targeted promotion to primary care physicians and specialists," Walbert said. In addition to Actimmune, the expanded revenue base would also include Horizon's current products, namely the anti-inflammatory drugs Duexis (famotidine/ibuprofen) and Vimovo (naproxen/esomeprazole), both of which are marketed in the US, as well as Rayos (prednisone) and its counterpart Lodotra, which are sold inside and outside the US, respectively.

The proposed acquisition, which the boards of both companies unanimously approved, is expected to close mid-year pending approval by Horizon shareholders. The companies estimate that the merger will result in combined revenues of $250 million to $265 million for 2014, with earnings between $65 million and $75 million, excluding certain one-time transaction expenses.
回复此楼
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
相关版块跳转 我要订阅楼主 ienjoysun 的主题更新
普通表情 龙 兔 虎 猫 高级回复 (可上传附件)
最具人气热帖推荐 [查看全部] 作者 回/看 最后发表
[考博] 27年药学 考博申请 +4 。12345 2026-11-14 5/250 2026-11-16 19:52 by 0611517sll
[硕博家园] 售SCI文章,我:8O5.5.1.O.54,科目齐全,可+急 +5 SX5mJmPWDfOO 2026-11-13 5/250 2026-11-16 13:40 by LrcgbaWjazY5
[考博] 售SCI文章,我:8O.5.5.1O.54,科目全,可十急 +3 SX5mJmPWDfOO 2026-11-13 3/150 2026-11-15 08:18 by xSrQNSSjcgoX
[论文投稿] 售SCI一区T0P文章,我:8O.55.1.O.5.4,科目齐全,可+急 +4 SX5mJmPWDfOO 2026-11-13 4/200 2026-11-15 07:45 by xSrQNSSjcgoX
[考研] 售SCI一区文章,我:8.O.55.1.O.54,科目齐全,可伽急 +3 uKOSCocCb6Fm 2026-11-13 3/150 2026-11-15 05:11 by xSrQNSSjcgoX
[硕博家园] 售一区SCI文章T0P,我:8O.551.O54,科目全,可十急 +3 uKOSCocCb6Fm 2026-11-12 6/300 2026-11-15 02:59 by xSrQNSSjcgoX
[公派出国] 售SCI一区文章,我:8.O.551.O.5.4,科目全,可伽急 +4 G2rhSvqvhNzl 2026-11-10 5/250 2026-11-13 11:37 by Equinoxhua
[考博] 售SCI一区文章,我:8.O.55.1.O.54,科目齐全,可伽急 +4 TgvkbZZl9tqB 2026-11-11 6/300 2026-11-12 12:42 by ECLTXnJnRSXf
[硕博家园] 售SCI一区文章,我:8.O.551.O.5.4,科目全,可伽急 +3 TgvkbZZl9tqB 2026-11-11 4/200 2026-11-12 12:28 by ECLTXnJnRSXf
[硕博家园] 售SCI一区T0P文章,我:8.O55.1.O.54,科目全,可十急 +4 cdqGD6ftHmbl 2026-11-11 4/200 2026-11-12 12:26 by ECLTXnJnRSXf
[考研] 售SCI一区T0P文章,我:8.O.55.1.O.5.4,科目全,可+急 +4 Z7qfCsdIiD1T 2026-11-11 5/250 2026-11-12 11:44 by HajghKOMynmz
[教师之家] 售SCI一区文章,我:8.O.551.O.5.4,科目全,可伽急 +4 Z7qfCsdIiD1T 2026-11-10 9/450 2026-11-12 11:22 by HajghKOMynmz
[教师之家] 售SCI文章,我:8O5.5.1.O.54,科目齐全,可+急 +4 Z7qfCsdIiD1T 2026-11-10 5/250 2026-11-12 11:14 by HajghKOMynmz
[教师之家] 售SCI一区T0P文章,我:8.O.55.1.O54,科目全,可伽急 +5 czAiolzR0IJC 2026-11-10 7/350 2026-11-12 11:09 by HajghKOMynmz
[硕博家园] 售SCI文章,我:8O.5.5.1O.54,科目全,可十急 +4 czAiolzR0IJC 2026-11-10 8/400 2026-11-12 10:49 by HajghKOMynmz
[教师之家] 售SCI一区T0P文章,我:8.O.55.1.O.5.4,科目全,可+急 +4 G2rhSvqvhNzl 2026-11-10 6/300 2026-11-12 10:38 by HajghKOMynmz
[公派出国] 售SCI一区T0P文章,我:8.O.55.1.O.5.4,科目全,可+急 +3 gRND4NVAZ8VG 2026-11-11 3/150 2026-11-12 07:42 by HajghKOMynmz
[公派出国] 售SCI一区T0P文章,我:8.O55.1.O.54,科目全,可十急 +4 Z7qfCsdIiD1T 2026-11-10 6/300 2026-11-12 07:09 by 9fOTqj074tIg
[硕博家园] 售SCI一区T0P文章,我:8.O.55.1.O.5.4,科目全,可+急 +3 C6CRn66RYYXS 2026-11-10 5/250 2026-11-12 06:03 by 9fOTqj074tIg
[教师之家] 售SCI文章,我:8O5.5.1.O.54,科目齐全,可+急 +4 C6CRn66RYYXS 2026-11-10 4/200 2026-11-12 06:03 by 9fOTqj074tIg
信息提示
请填处理意见